Plasma netrin-1 is a diagnostic biomarker of human cancers

Biomarkers

Volumn 16, Issue 2, 2011, Pages 172-180

  Ramesh, Ganesan ^a   Berg, Arthur ^b   Jayakumar, Calpurnia ^b  

^a MEDICAL COLLEGE OF GEORGIA   (United States)

^b PENN STATE COLLEGE OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

NETRIN 1; TUMOR MARKER;

ADENOCARCINOMA; ADULT; ARTICLE; COLON CARCINOMA; CONTROLLED STUDY; DIAGNOSTIC VALUE; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; GLIOBLASTOMA; HUMAN; HUMAN TISSUE; HYPOPHYSIS ADENOMA; IMMUNOHISTOCHEMISTRY; INTRADUCTAL CARCINOMA; KIDNEY CARCINOMA; LIVER ADENOCARCINOMA; LUNG ADENOCARCINOMA; MAJOR CLINICAL STUDY; MALE; MENINGIOMA; PANCREAS ADENOCARCINOMA; PROGNOSIS; PROSTATE ADENOCARCINOMA; QUANTITATIVE ANALYSIS; SENSITIVITY AND SPECIFICITY;

AXONS; CASE-CONTROL STUDIES; DROSOPHILA PROTEINS; FEMALE; HUMANS; IMMUNOHISTOCHEMISTRY; MALE; MIDDLE AGED; NEOPLASMS; NERVE GROWTH FACTORS; SENSITIVITY AND SPECIFICITY; TUMOR MARKERS, BIOLOGICAL; TUMOR SUPPRESSOR PROTEINS;

EID: 79951858900     PISSN: 1354750X     EISSN: 13665804     Source Type: Journal    
DOI: 10.3109/1354750X.2010.541564     Document Type: Article

References (32)

1. Arakawa H. (2004). Netrin-1 and its receptors in tumorigenesis. Nat Rev Cancer 4:978-987. (Pubitemid 39626221)
2. Barallobre MJ, Pascual M, Del Rí,o JA, Soriano E. (2005). The Netrin family of guidance factors: emphasis on Netrin-1 signalling. Brain Res Brain Res Rev 49:22-47. (Pubitemid 40803502)
3. Bernet A, Mazelin L, Coissieux MM, Gadot N, Ackerman SL, Scoazec JY, Mehlen P. (2007). Inactivation of the UNC5C Netrin-1 receptor is associated with tumor progression in colorectal malignancies. Gastroenterology 133:1840-1848. (Pubitemid 350186160)
4. Bernet A, Fitamant J. (2008). Netrin-1 and its receptors in tumour growth promotion. Expert Opin Ther Targets 12:995-1007.
5. Reeves WB, Kwon O, Ramesh G. (2008). Netrin-1 and kidney injury. II. Netrin-1 is an early biomarker of acute kidney injury. Am J Physiol Renal Physiol 294:F731-F738.
6. Cho WC. (2007). Contribution of oncoproteomics to cancer biomarker discovery. Mol Cancer 6:25.
7. Chow WH, Devesa SS, Warren JL, Fraumeni JF Jr. (1999). Rising incidence of renal cell cancer in the United States. Jama 281:1628-1631. (Pubitemid 29211773)
8. Delloye-Bourgeois C, Fitamant J, Paradisi A, Cappellen D, Douc- Rasy S, Raquin MA, Stupack D, Nakagawara A, Rousseau R, Combaret V, Puisieux A, Valteau-Couanet D, Bénard J, Bernet A, Mehlen P. (2009). Netrin-1 acts as a survival factor for aggressive neuroblastoma. J Exp Med 206:833-847.
9. Delloye-Bourgeois C, Brambilla E, Coissieux MM, Guenebeaud C, Pedeux R, Firlej V, Cabon F, Brambilla C, Mehlen P, Bernet A. (2009). Interference with netrin-1 and tumor cell death in nonsmall cell lung cancer. J Natl Cancer Inst 101:237-247.
10. Dumartin L, Quemener C, Laklai H, Herbert J, Bicknell R, Bousquet C, Pyronnet S, Castronovo V, Schilling MK, Bikfalvi A, Hagedorn M. (2010). Netrin-1 mediates early events in pancreatic adenocarcinoma progression, acting on tumor and endothelial cells. Gastroenterology 138:1595-606, 1606.e1.
11. Ferlay J, Autier P, Boniol M, Heanue M, Colombet M, Boyle P. (2007). Estimates of the cancer incidence and mortality in Europe in 2006. Ann Oncol 18:581-592. (Pubitemid 46359643)
12. Fitamant J, Guenebeaud C, Coissieux MM, Guix C, Treilleux I, Scoazec JY, Bachelot T, Bernet A, Mehlen P. (2008). Netrin-1 expression confers a selective advantage for tumor cell survival in metastatic breast cancer. Proc Natl Acad Sci USA 105:4850-4855. (Pubitemid 351753835)
13. Jemal A, Siegel R, Ward E, Murray T, Xu J, Smigal C, Thun MJ. (2006). Cancer statistics, 2006. CA Cancer J Clin 56:106-130.
14. Kaufmann S, Kuphal S, Schubert T, Bosserhoff AK. (2009). Functional implication of Netrin expression in malignant melanoma. Cell Oncol 31:415-422.
15. Link BC, Reichelt U, Schreiber M, Kaifi JT, Wachowiak R, Bogoevski D, Bubenheim M, Cataldegirmen G, Gawad KA, Issa R, Koops S, Izbicki JR, Yekebas EF. (2007). Prognostic implications of netrin-1 expression and its receptors in patients with adenocarcinoma of the pancreas. Ann Surg Oncol 14:2591-2599. (Pubitemid 47389585)
16. Llambi F, Lourenço FC, Gozuacik D, Guix C, Pays L, Del Rio G, Kimchi A, Mehlen P. (2005). The dependence receptor UNC5H2 mediates apoptosis through DAP-kinase. Embo J 24:1192-1201. (Pubitemid 40516602)
17. Llambi F, Causeret F, Bloch-Gallego E, Mehlen P. (2001). Netrin-1 acts as a survival factor via its receptors UNC5H and DCC. Embo J 20:2715-2722. (Pubitemid 32938556)
18. Ly NP, Komatsuzaki K, Fraser IP, Tseng AA, Prodhan P, Moore KJ, Kinane TB. (2005). Netrin-1 inhibits leukocyte migration in vitro and in vivo. Proc Natl Acad Sci USA 102:14729-14734. (Pubitemid 41457124)
19. Mehlen P, Guenebeaud C. (2010). Netrin-1 and its dependence receptors as original targets for cancer therapy. Curr Opin Oncol 22:46-54.
20. Mirakaj V, Thix CA, Laucher S, Mielke C, Morote-Garcia JC, Schmit MA, Henes J, Unertl KE, Köhler D, Rosenberger P. (2010). Netrin-1 dampens Pulmonary Inflammation during Acute Lung Injury. Am J Respir Crit Care Med 200905-0717OC.
21. Navankasattusas S, Whitehead KJ, Suli A, Sorensen LK, Lim AH, Zhao J, Park KW, Wythe JD, Thomas KR, Chien CB, Li DY. (2008). The netrin receptor UNC5B promotes angiogenesis in specific vascular beds. Development 135:659-667. (Pubitemid 351405019)
22. Nguyen A, Cai H. (2006). Netrin-1 induces angiogenesis via a DCC-dependent ERK1/2-eNOS feed-forward mechanism. Proc Natl Acad Sci USA 103:6530-6535.
23. Paradisi A, Maisse C, Coissieux MM, Gadot N, Lépinasse F, Delloye-Bourgeois C, Delcros JG, Svrcek M, Neufert C, Fléjou JF, Scoazec JY, Mehlen P. (2009). Netrin-1 up-regulation in inflammatory bowel diseases is required for colorectal cancer progression. Proc Natl Acad Sci USA 106:17146-17151.
24. Rabinovitz I, Mercurio AM. (1997). The integrin alpha6beta4 functions in carcinoma cell migration on laminin-1 by mediating the formation and stabilization of actin-containing motility structures. J Cell Biol 139:1873-1884. (Pubitemid 28079249)
25. Ramesh G, Krawczeski CD, Woo JG, Wang Y, Devarajan P. (2010). Urinary netrin-1 is an early predictive biomarker of acute kidney injury after cardiac surgery. Clin J Am Soc Nephrol 5:395-401.
26. Rosenberger P, Schwab JM, Mirakaj V, Masekowsky E, Mager A, Morote-Garcia JC, Unertl K, Eltzschig HK. (2009). Hypoxia- inducible factor-dependent induction of netrin-1 dampens inflammation caused by hypoxia. Nat Immunol 10:195-202.
27. Stanco A, Szekeres C, Patel N, Rao S, Campbell K, Kreidberg JA, Polleux F, Anton ES. (2009). Netrin-1-alpha3beta1 integrin interactions regulate the migration of interneurons through the cortical marginal zone. Proc Natl Acad Sci USA 106:7595-7600.
28. Sturgeon CM, Lai LC, Duffy MJ. (2009). Serum tumour markers: how to order and interpret them. Bmj 339:b3527.
29. Wang W, Reeves WB, Ramesh G. (2008). Netrin-1 and kidney injury. I. Netrin-1 protects against ischemia-reperfusion injury of the kidney. Am J Physiol Renal Physiol 294:F739-F747.
30. Wilson BD, Ii M, Park KW, Suli A, Sorensen LK, Larrieu-Lahargue F, Urness LD, Suh W, Asai J, Kock GA, Thorne T, Silver M, Thomas KR, Chien CB, Losordo DW, Li DY. (2006). Netrins promote developmental and therapeutic angiogenesis. Science 313:640-644. (Pubitemid 44201136)
31. Yang Y, Zou L, Wang Y, Xu KS, Zhang JX, Zhang JH. (2007). Axon Guidance Cue Netrin-1 has Dual Function in Angiogenesis. Cancer Biol Ther 6:743-748. (Pubitemid 47328356)
32. Yebra M, Montgomery AM, Diaferia GR, Kaido T, Silletti S, Perez B, Just ML, Hildbrand S, Hurford R, Florkiewicz E, Tessier-Lavigne M, Cirulli V. (2003). Recognition of the neural chemoattractant Netrin-1 by integrins alpha6beta4 and alpha3beta1 regulates epithelial cell adhesion and migration. Dev Cell 5:695-707 (Pubitemid 37362214)